BMB Reports : eISSN 1976-670X

Cited by CrossRef (13)

  1. Chaoyan Yue, Chunyi Zhang, Chunmei Ying, Hua Jiang. Diabetes associated with cervical carcinoma among high-risk HPV-infected patients with cytologically diagnosed high grade squamous intraepithelial lesion. Front. Endocrinol. 2022;13
    https://doi.org/10.3389/fendo.2022.993785
  2. Pengbin Ping, Juan Li, Hongbin Lei, Xiaoying Xu. Fatty acid metabolism: A new therapeutic target for cervical cancer. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1111778
  3. Amir Akdam, Liel Van Mil, Yossi Tzur, Ido Laskov, Dan Grisaru, Eduardo Schejter, Nadav Michaan. Human Papilloma Virus Typing as a Triage Tool for Women with Postcoital Bleeding: A Retrospective Cohort Study. Journal of Women's Health 2024;33:734
    https://doi.org/10.1089/jwh.2023.0616
  4. Jing Zeng, Wei Jiang, Kemin Li, Mengpei Zhang, Jinghong Chen, Yuanqiong Duan, Qingli Li, Rutie Yin. Clinical and pathological characteristics of cervical clear cell carcinoma in patients not exposed to diethylstilbestrol: a comprehensive analysis of 49 cases. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1430742
  5. Peiyu Mao, Chen Zhang, Xinyan Wang, Huadi Yang. Copious vaginal discharge finally diagnosed as cervical adenocarcinoma: A case report. 2023;102:e33614
    https://doi.org/10.1097/MD.0000000000033614
  6. Lingyu Lei, Lin Zhang, Yahong Zheng, Wei Ma, Fang Liu, Dongmei Li, Keming Chen, Yong Zeng. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study. BMC Cancer 2024;24
    https://doi.org/10.1186/s12885-024-12342-2
  7. Isadora Oliveira Ansaloni Pereira, Nayara Nascimento Toledo Silva, Angelica Alves Lima, Glenda Nicioli da Silva. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review. Environ and Mol Mutagen 2024;65:143
    https://doi.org/10.1002/em.22591
  8. Zsuzsanna Schelz, Hiba F. Muddather, Fatemeh Sheihaki Jaski, Noémi Bózsity, István Zupkó. An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer. CIMB 2024;46:6566
    https://doi.org/10.3390/cimb46070391
  9. Alexandra D. Michel, Holly B. Fontenot, Lindsay Fuzzell, Naomi C. Brownstein, Paige Lake, Susan T. Vadaparampil, Rebecca B. Perkins. Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Cancer 2024;130:2325
    https://doi.org/10.1002/cncr.35269
  10. Mei Meng, Yan Guo, Yu Chen, Xu Li, Bin Zhang, Zhijia Xie, Juntao Liu, Zhe Zhao, Yuxi Liu, Tong Zhang, Yingnan Qiao, Bingxue Shang, Quansheng Zhou. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways. Cell Oncol. 2024;47:657
    https://doi.org/10.1007/s13402-023-00891-w
  11. Md Tamzid Hossain Tanim, Sudipta Deb Nath, Sumaiya Farah Khan, Abira Khan, Abu Ashfaqur Sajib. Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs. Cancer Treatment and Research Communications 2024;39:100808
    https://doi.org/10.1016/j.ctarc.2024.100808
  12. Yan Ma, Qian-Qian Yang, Dong-Mei Gu, Xiao Yuan, Yu-Hong Wang, Ling-Chuan Guo. Canadine inhibits epithelial mesenchymal transformation of HPV-negative cervical cancer. Tissue Barriers 2023
    https://doi.org/10.1080/21688370.2023.2256641
  13. Nika Vučković, Karin Hoppe-Seyler, Angelika B. Riemer. Characterization of DoTc2 4510—Identifying HPV16 Presence in a Cervical Carcinoma Cell Line Previously Considered to Be HPV-Negative. Cancers 2023;15:3810
    https://doi.org/10.3390/cancers15153810